Tiffany Olson

Tiffany Olson is a seasoned executive with extensive experience in healthcare, precision medicine, and logistics. Currently serving as a Board Member for Telix Innovations, MiMedx, Castle Biosciences, and Langham Logistics, Tiffany is dedicated to advancing cancer treatment and enhancing patient care through innovative strategies. Previous roles include President of Nuclear & Precision Health Solutions at Cardinal Health, where Tiffany oversaw significant operational aspects, and Board Member at Asuragen and BioTelemetry, contributing to market growth and governance. Tiffany holds a Bachelor's degree from the University of Minnesota's Carlson School of Management and an MBA from the University of St. Thomas's Opus College of Business. Additionally, Tiffany is a member of Pavilion and GLG, further showcasing a commitment to sharing knowledge and driving innovation in the healthcare industry.